Intra-Empyema Antibiotic Administration: A Case Report
DOI:
https://doi.org/10.37275/amcr.v5i2.509Keywords:
Empyema, Intralesional, Muscular atrophy, Pleural, Spinal antibioticAbstract
Untreated empyema has a great morbidity and is potentially lethal. The usual approach for treatment is intravenous antibiotics together with chest tube insertion or thoracoscopic/ surgical interventions. The patient was a 32-year-old man with spinal muscular atrophy and severe intercostal muscular weakness presented with localized pleuritic chest pain and fever. The cause was diagnosed to be parapneumonic empyema. In this case, invasive approaches would potentially exacerbated chest musculature weakness. Other non-invasive managements CT-guided needle drainage and intravenous antibiotic therapy were tried and proved to be ineffective for the patient and the next invasive step would pose considerable risk to the patient. Intra-empyemic antibiotic administration through a small tube catheter was successfully effective without any recurrence. This method was non-invasive with no significant risk to the patient, had a low cost and was accepted by the patient. It was shown to be effective without any complication and saved the patient from performing an invasive procedure. This non-invasive approach may be used in those patients who are of high risk for invasive procedures. Also, potentially it may be used as one of the first line approaches before performing more invasive modalities.
Authors
- Laleh Hakemi1*
- Pirhossein Kolivand2
- Naereh Khodashenas Firoozabadi1
- 1Pain Department, Shefa Neuroscience Research Center, Tehran, Iran
- 2Department of Health Economics, School of Medicine, Shahed University, Tehran, Iran
Corresponding author Laleh Hakemi — lalehakemi@yahoo.com
Downloads
Published
Issue
Section
License
Authors retain copyright and grant Archives of The Medicine and Case Reports (AMCR) the right of first publication. Published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC BY-NC-SA 4.0). This license permits users to copy, redistribute, and adapt the work for non-commercial purposes, provided that appropriate credit is given, a link to the license is supplied, changes are indicated, and adaptations are distributed under the same license. Copyright in the journal website, logo, layout, and other publisher-owned materials does not transfer copyright in individual articles.
How to Cite
Article Metrics
Views and downloads recorded by this journal. Citation count from OpenAlex.